This inventor holds 1 USPTO granted patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Kiyoshi Nakazawa: Innovator in Tumor Cell Growth Inhibition
Introduction
Kiyoshi Nakazawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical research, particularly in the development of tumor cell growth inhibitors. His innovative work has the potential to impact cancer treatment and improve patient outcomes.
Latest Patents
Kiyoshi Nakazawa holds a patent for "Human-derived tumor cell growth inhibitors." This patent represents a crucial advancement in the fight against cancer, showcasing his dedication to medical innovation.
Career Highlights
Nakazawa is currently employed at Taisho Pharmaceutical Co., Ltd., where he continues to work on groundbreaking research. His career is marked by a commitment to developing effective treatments that can enhance the quality of life for patients suffering from cancer.
Collaborations
Throughout his career, Kiyoshi Nakazawa has collaborated with notable colleagues, including Toshi Komurasaki and Hitoshi Toyoda. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Kiyoshi Nakazawa's contributions to the field of tumor cell growth inhibition highlight his role as a key innovator in medical research. His work at Taisho Pharmaceutical Co., Ltd. and his collaborations with esteemed colleagues further emphasize his commitment to advancing cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile